YONITA
Natural health product licensed in Canada
- Licence holder
- Pranic Forest Artisan Apothecary Corp.
- NPN or DIN-HM
- 80080991
- Status
- Active licence
- Licence date
- 1 November 2017
- Revision date
- Not provided
- Form
- Huile
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Cymbopogon citratus Source : Sommité | 2.5 % |
| Pelargonium graveolens Source : Sommité en fleurs (herbe) | 1.6 % |
| Melaleuca alternifolia Source : Feuille | 0.83 % |
Non-medicinal ingredients
Extrait d'Usnea barbata (Lichen)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Huile | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Used in aromatherapy as a nervine/calmative. Tea Tree is Used in aromatherapy to help relieve colds.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you have broken, irritated, or sensitive skin, do not use this product.
- Précautions et mises en garde
Keep out of the reach of children. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use. Avoid exposure of applied area(s) to the sun. Do not expose the applied area(s) to the sun for 24 to 48 hours after application. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center.
Source
Official Health Canada record, licence 80080991
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.